Evidence map›Paper›PMID 36599300›Full record

ArticleCell metabolism2023

Profiling mouse brown and white adipocytes to identify metabolically relevant small ORFs and functional microproteins.

Thomas F Martinez, Sally Lyons-Abbott, Angie L Bookout, Eduardo V De Souza, Cynthia Donaldson, Joan M Vaughan, Calvin Lau, Ariel Abramov, Arian F Baquero, Karalee Baquero and 21 more

Open access · hybridAbstract read
In one paragraph

Article in Cell metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. bioRxiv : the preprint server for biology · 2026
    Article
  10. Cold exposure-inducedActa pharmaceutica Sinica. B · 2026
    Article
  11. Article
  12. Article
  13. Identification and Characterization of Microproteins/ MicroORFs.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  14. Review
  15. Review
  16. Chasing the Ghost Proteome in the Dark Matter.Molecular & cellular proteomics : MCP · 2025
    Review
  17. The Long Non-coding RNA Landscape of Endurance Exercise Training.bioRxiv : the preprint server for biology · 2025
    Article
  18. Review
  19. Article
  20. CRISPR-Cas9 screening reveals microproteins regulating adipocyte proliferation and lipid metabolism.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 6 institutions in 3 countries.

Thomas F MartinezDepartment of Pharmaceutical Sciences, Department of Biological Chemistry, Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, USA.
Sally Lyons-AbbottNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Angie L BookoutNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Eduardo V De SouzaCentro de Pesquisas em Biologia Molecular e Funcional (CPBMF) and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Programa de Pós-Graduação em Biologia Celular e Molecular, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul 90616-900, Brazil; Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA.
Cynthia DonaldsonClayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA.
Joan M VaughanClayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA.
Calvin LauClayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA.
Ariel AbramovNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Arian F BaqueroNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Karalee BaqueroNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Dave FriedrichNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Justin HuardNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Ray DavisNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Bong KimNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Ty KochNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Aaron J MercerNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Ayesha MisquithNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Sara A MurrayNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Sakara PerryNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Lindsay K PinoDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.
Christina SanfordNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Alex SimonNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Yu ZhangNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Garrett ZippNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Cristiano V BizarroCentro de Pesquisas em Biologia Molecular e Funcional (CPBMF) and Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil; Programa de Pós-Graduação em Biologia Celular e Molecular, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul 90616-900, Brazil.
Maxim N ShokhirevRazavi Newman Integrative Genomics and Bioinformatics Core, Salk Institute for Biological Studies, La Jolla, CA, USA.
Andrew J WhittleNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.
Brian C SearleDepartment of Biomedical Informatics, The Ohio State University, Columbus, OH, USA.
Michael J MacCossDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.
Alan SaghatelianClayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, CA, USA. Electronic address: asaghatelian@salk.edu.
Christopher A BarnesNovo Nordisk Research Center Seattle, Inc., Seattle, WA, USA; Velia Therapeutics, Inc., San Diego, CA, USA. Electronic address: chrisb@rnes.pro.
Novo Nordisk (United States) · USSalk Institute for Biological Studies · USUniversity of Washington · USPontifícia Universidade Católica do Rio Grande do Sul · BRThe Ohio State University · USUniversity of California, Irvine · US

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Reuben Shaw · 1985 to 2026
$82.8M
TrainingP41GM103533 · NIGMS · UNIVERSITY OF WASHINGTON · PI YATES III, JOHN R · 2012 to 2021
$20.7M
Project 4: Novel reagent development to enable molecular characterizationU19AG065156 · NIA · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2020 to 2024
$15.9M
An Encyclopedia of the Adipose Tissue Secretome to Identify Mediators of Health and DiseaseRC2DK129961 · NIDDK · ROCKEFELLER UNIVERSITY · PI CHAIT, BRIAN T, COHEN, PAUL · 2021 to 2025
$9.2M
Seattle Quant: A Resource for the Skyline Software EcosystemR24GM141156 · NIGMS · UNIVERSITY OF WASHINGTON · PI Michael MacCoss · 2021 to 2026
$6.7M
The Discovery of Human Peptide Encoding GenesR01GM102491 · NIGMS · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI O'SHEA, CLODAGH, SAGHATELIAN, ALAN · 2012 to 2025
$5.5M
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetesU01DK137097 · NIDDK · UNIVERSITY OF WASHINGTON · PI ANDREW N HOOFNAGLE, Michael MacCoss · 2023 to 2026
$3.4M
A universal multiplexing approach to unlock the hidden proteomeR01GM133981 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SWANEY, DANIELLE L · 2019 to 2022
$1.3M
The Roles of a Novel Microprotein in Wound Healing and CancerK01CA249038 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI MARTINEZ, THOMAS FARID · 2021 to 2025
$688k
NCI NIH HHS K01 CA249038NCI NIH HHS P30 CA014195NIA NIH HHS U19 AG065156NIDDK NIH HHS RC2 DK129961NIDDK NIH HHS U01 DK137097NIGMS NIH HHS P41 GM103533NIGMS NIH HHS R01 GM102491NIGMS NIH HHS R01 GM133981NIGMS NIH HHS R24 GM141156
6 · The paper itself

Abstract

Microproteins (MPs) are a potentially rich source of uncharacterized metabolic regulators. Here, we use ribosome profiling (Ribo-seq) to curate 3,877 unannotated MP-encoding small ORFs (smORFs) in primary brown, white, and beige mouse adipocytes. Of these, we validated 85 MPs by proteomics, including 33 circulating MPs in mouse plasma. Analyses of MP-encoding mRNAs under different physiological conditions (high-fat diet) revealed that numerous MPs are regulated in adipose tissue in vivo and are co-expressed with established metabolic genes. Furthermore, Ribo-seq provided evidence for the translation of Gm8773, which encodes a secreted MP that is homologous to human and chicken FAM237B. Gm8773 is highly expressed in the arcuate nucleus of the hypothalamus, and intracerebroventricular administration of recombinant mFAM237B showed orexigenic activity in obese mice. Together, these data highlight the value of this adipocyte MP database in identifying MPs with roles in fundamental metabolic and physiological processes such as feeding.

Indexed as

Adipocytes, WhiteAdipose Tissue, BrownAdipocytes, BrownAdipose Tissue, WhiteAnimalsHumansMiceMicropeptidesOpen Reading FramesMicropeptidesbrown adipose tissuedata-independent acquisition mass spectrometrydiet-induced obesitymicroproteinsRibo-seqribosome profilingsecreted microproteinssmall ORFswhite adipose tissue

Identifiers

PMID36599300
PMCPMC9889109
OpenAlexW4313531883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.